{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:47:08Z","timestamp":1790819228696,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.medmal.2008.06.031","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T13:33:46Z","timestamp":1219239226000},"page":"524-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vaccination contre la fi\u00e8vre jaune en dehors des sujets immunocomp\u00e9tents"],"prefix":"10.1016","volume":"38","author":[{"given":"M.","family":"Bruyand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Receveur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-H.","family":"Verdi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Malvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.medmal.2008.06.031_bib1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"40","key":"10.1016\/j.medmal.2008.06.031_bib2","first-page":"349","article-title":"Yellow fever vaccine: WHO position paper","volume":"78","author":"WHO","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"issue":"RR-17","key":"10.1016\/j.medmal.2008.06.031_bib3","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"9426","key":"10.1016\/j.medmal.2008.06.031_bib4","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(04)16459-3","article-title":"Live flavivirus vaccines: reasons for caution","volume":"363","author":"Seligman","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.medmal.2008.06.031_bib5","first-page":"272","article-title":"Vaccinations chez les patients immunod\u00e9prim\u00e9s","volume":"148","author":"Bouchaud","year":"1997","journal-title":"Ann Med Interne (Paris)"},{"issue":"4","key":"10.1016\/j.medmal.2008.06.031_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.medmal.2008.06.031_bib7","first-page":"1056","article-title":"Antibody response to 17D yellow fever vaccine in Ghanaian infants","volume":"79","author":"Osei-Kwasi","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.medmal.2008.06.031_bib8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/522182","article-title":"Immune reconstitution syndrome and exacerbation of infections after pregnancy","volume":"45","author":"Singh","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.medmal.2008.06.031_bib9","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.178.6.3345","article-title":"Maternal acceptance of the fetus: true human tolerance","volume":"178","author":"Guleria","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.medmal.2008.06.031_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0035-9203(93)90156-K","article-title":"Yellow fever vaccination and pregnancy: a four-year prospective study","volume":"87","author":"Nasidi","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.medmal.2008.06.031_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.vaccine.2005.09.033","article-title":"The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil","volume":"24","author":"Suzano","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.medmal.2008.06.031_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.idc.2004.11.004","article-title":"Yellow fever and Japanese encephalitis vaccines: indications and complications","volume":"19","author":"Marfin","year":"2005","journal-title":"Infect Dis Clin North Am"},{"issue":"9276","key":"10.1016\/j.medmal.2008.06.031_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.medmal.2008.06.031_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0167-5699(95)80064-6","article-title":"The immunology of exceptional individuals: the lesson of centenarians","volume":"16","author":"Franceschi","year":"1995","journal-title":"Immunol Today"},{"issue":"10","key":"10.1016\/j.medmal.2008.06.031_bib15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1286-4579(01)01443-5","article-title":"Immunosenescence and infectious diseases","volume":"3","author":"Ginaldi","year":"2001","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.medmal.2008.06.031_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1631-0691(02)01505-6","article-title":"Immunos\u00e9nescence","volume":"325","author":"Bach","year":"2002","journal-title":"C R Biol"},{"issue":"4","key":"10.1016\/j.medmal.2008.06.031_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0047-6374(03)00019-8","article-title":"Age-related changes in population of peripheral T cells: towards a model of immunosenescence","volume":"124","author":"Romanyukha","year":"2003","journal-title":"Mech Ageing Dev"},{"issue":"9","key":"10.1016\/j.medmal.2008.06.031_bib18","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/322968","article-title":"Travel vaccines and elderly persons: review of vaccines available in the United States","volume":"33","author":"Leder","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.medmal.2008.06.031_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"25","key":"10.1016\/j.medmal.2008.06.031_bib20","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.medmal.2008.06.031_bib21","first-page":"2254","article-title":"Travel immunizations: benefits and precautions","volume":"71","author":"Walden","year":"2005","journal-title":"Am Fam Physician"},{"issue":"12","key":"10.1016\/j.medmal.2008.06.031_bib22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00006454-199712000-00015","article-title":"Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1","volume":"16","author":"Sibailly","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.medmal.2008.06.031_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vaccine.2004.05.018","article-title":"Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast","volume":"23","author":"Fitzner","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.medmal.2008.06.031_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00002030-199903110-00015","article-title":"Estimation of HIV-1 prevalence in the population of Abidjan by adjustment of the prevalence observed in antenatal centres","volume":"13","author":"Desgrees du Lou","year":"1999","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.medmal.2008.06.031_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00002030-200403260-00020","article-title":"Yellow fever vaccine is safe and effective in HIV-infected patients","volume":"18","author":"Tattevin","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.medmal.2008.06.031_bib26","first-page":"238","article-title":"Immunog\u00e9nicit\u00e9 et tol\u00e9rance du vaccin amaril chez le voyageur vivant avec le VIH, France, 2005","volume":"25\u201326","author":"Pistone","year":"2007","journal-title":"BEH"},{"issue":"1","key":"10.1016\/j.medmal.2008.06.031_bib27","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"10.1016\/j.medmal.2008.06.031_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clim.2004.02.008","article-title":"Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity","volume":"112","author":"Moylett","year":"2004","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.medmal.2008.06.031_bib29","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1542\/peds.112.4.e325","article-title":"Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"112","author":"Perez","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.medmal.2008.06.031_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2004.04.004","article-title":"Live viral vaccines in patients with DiGeorge syndrome","volume":"113","author":"Sullivan","year":"2004","journal-title":"Clin Immunol"},{"issue":"14","key":"10.1016\/j.medmal.2008.06.031_bib31","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.vaccine.2004.10.005","article-title":"Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome)","volume":"23","author":"Azzari","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.06.031_bib32","unstructured":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42(RR-4):1\u201318."},{"issue":"7","key":"10.1016\/j.medmal.2008.06.031_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0929-693X(00)00308-0","article-title":"Vaccination de l\u2019enfant trait\u00e9 pour tumeur solide\u00a0: quelle conduite tenir\u00a0?","volume":"8","author":"Marec-Berard","year":"2001","journal-title":"Arch Pediatr"},{"issue":"2","key":"10.1016\/j.medmal.2008.06.031_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/biol.1997.0090","article-title":"Vaccination of the immunocompromised patient","volume":"25","author":"Loutan","year":"1997","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.medmal.2008.06.031_bib35","first-page":"145","article-title":"Transplant\u00e9 r\u00e9nal et voyage tropical","volume":"20","author":"Receveur","year":"1999","journal-title":"N\u00e9phrologie"},{"issue":"3","key":"10.1016\/j.medmal.2008.06.031_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CMR.16.3.357-364.2003","article-title":"Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols","volume":"16","author":"Duchini","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2008.06.031_bib37","first-page":"95","article-title":"Vaccination for yellow fever after bone marrow transplantation","volume":"17","author":"Rio","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.medmal.2008.06.031_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0609.2004.00218.x","article-title":"Yellow fever vaccine: a successful vaccination of an immunocompromised patient","volume":"72","author":"Gowda","year":"2004","journal-title":"Eur J Haematol"},{"issue":"8","key":"10.1016\/j.medmal.2008.06.031_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1704870","article-title":"Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT","volume":"35","author":"Ljungman","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"9438","key":"10.1016\/j.medmal.2008.06.031_bib40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Barwick","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.medmal.2008.06.031_bib41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.medmal.2008.06.031_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jcp.56.1.12","article-title":"What is Good\u2019s syndrome? Immunological abnormalities in patients with thymoma","volume":"56","author":"Kelleher","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.medmal.2008.06.031_bib43","series-title":"Principes de M\u00e9decine Interne","author":"Braunwald","year":"2001"},{"issue":"2","key":"10.1016\/j.medmal.2008.06.031_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.medmal.2008.06.031_bib45","first-page":"351","article-title":"Vaccinations et maladies syst\u00e9miques. Vaccinations et immunod\u00e9pression","volume":"149","author":"Bouchaud","year":"1998","journal-title":"Ann Med Interne (Paris)"},{"issue":"15","key":"10.1016\/j.medmal.2008.06.031_bib46","first-page":"1631","article-title":"Faut-il vacciner les patients atteints de maladies auto-immunes\u00a0?","volume":"54","author":"Meyer","year":"2004","journal-title":"Rev Prat"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X08001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X08001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:04:45Z","timestamp":1759971885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X08001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0399077X08001881"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2008.06.031","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination contre la fi\u00e8vre jaune en dehors des sujets immunocomp\u00e9tents","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2008.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}